112 related articles for article (PubMed ID: 22687416)
1. Biliary excretion of curcumin is mediated by multidrug resistance-associated protein 2.
Lee JH; Oh JH; Lee YJ
Biol Pharm Bull; 2012; 35(5):777-80. PubMed ID: 22687416
[TBL] [Abstract][Full Text] [Related]
2. Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats.
Lee JH; Kim HG; Oh JH; Lee YJ
J Pharm Pharmacol; 2013 Mar; 65(3):423-9. PubMed ID: 23356851
[TBL] [Abstract][Full Text] [Related]
3. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
4. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Moriwaki T; Yasui H; Yamamoto A
Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
[TBL] [Abstract][Full Text] [Related]
7. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
9. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Nishino A; Kato Y; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
[TBL] [Abstract][Full Text] [Related]
10. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
Akao T; Sato K; Hanada M
Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
[TBL] [Abstract][Full Text] [Related]
11. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
Johnson DR; Klaassen CD
Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
[TBL] [Abstract][Full Text] [Related]
12. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
Hirohashi T; Suzuki H; Ito K; Ogawa K; Kume K; Shimizu T; Sugiyama Y
Mol Pharmacol; 1998 Jun; 53(6):1068-75. PubMed ID: 9614210
[TBL] [Abstract][Full Text] [Related]
13. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
14. Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats.
Fukuda H; Ohashi R; Ohashi N; Yabuuchi H; Tamai I
Drug Metab Dispos; 2010 Sep; 38(9):1505-13. PubMed ID: 20538722
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR).
Takikawa H; Nishikawa K; Sano N; Yamanaka M; Horie T
Dig Dis Sci; 1995 Aug; 40(8):1792-7. PubMed ID: 7648982
[TBL] [Abstract][Full Text] [Related]
16. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat.
Deters M; Klabunde T; Meyer H; Resch K; Kaever V
Planta Med; 2003 Apr; 69(4):337-43. PubMed ID: 12709901
[TBL] [Abstract][Full Text] [Related]
17. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
18. Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver.
Ji B; Ito K; Sekine S; Tajima A; Horie T
Free Radic Biol Med; 2004 Dec; 37(11):1718-29. PubMed ID: 15528031
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
20. Biliary excretion of azelnidipine, a calcium antagonist, in rats.
Hanawa N; Sano N; Takikawa H
J Gastroenterol Hepatol; 2004 Apr; 19(4):413-7. PubMed ID: 15012778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
